Daniella Beckman

Daniella Beckman, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Tango Therapeutics, Inc. and Blueprint Medicines Corp. In total, 17 filings cover trades dated from 8 December 2021 to 3 February 2026.

On the market, this insider has only sold: 6 sales, €175k in total. Outside the open market, there are 9 share grants. So far in 2026, the count stands at no purchases and 2 sales.

The latest filing, published on 4 February 2026, reports an open-market sale of €106k in Tango Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.